Wang Xiao

ORCID: 0000-0002-3707-3460
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Nanoparticle-Based Drug Delivery
  • Mesoporous Materials and Catalysis
  • Graphene and Nanomaterials Applications
  • Tuberculosis Research and Epidemiology
  • Antibiotic Resistance in Bacteria
  • Nanocomposite Films for Food Packaging
  • Anodic Oxide Films and Nanostructures
  • Plant Surface Properties and Treatments
  • Advanced biosensing and bioanalysis techniques
  • Antibiotic Use and Resistance
  • Mycobacterium research and diagnosis
  • Nanoparticles: synthesis and applications
  • Nematode management and characterization studies
  • Advanced ceramic materials synthesis
  • Polymer Nanocomposites and Properties
  • Synthesis of Tetrazole Derivatives
  • Polymer-Based Agricultural Enhancements
  • Anesthesia and Pain Management
  • Pain Management and Opioid Use
  • Nanoporous metals and alloys
  • Dendrimers and Hyperbranched Polymers
  • Synthesis and Characterization of Heterocyclic Compounds
  • Zeolite Catalysis and Synthesis
  • Nanoplatforms for cancer theranostics
  • Metal-Organic Frameworks: Synthesis and Applications

Central China Normal University
2016-2025

Institut Gustave Roussy
2022

Beijing Health Vocational College
2022

Université Paris-Saclay
2022

Chinese Academy of Medical Sciences & Peking Union Medical College
2021

Xiaomi (China)
1997

As the second most important fungal pathogen, Botrytis cinerea (B. cinerea) poses a serious threat to crop yields and agricultural safety. Pyraclostrobin (PYR), broad-spectrum QoI fungicide, has been widely utilized since its launch in 2003. However, inhibitory effects of both PYR technical formulations on B. are not outstanding. Even at concentration 50 μg/mL, inhibition rates by remain below 85%. In this work, we prepared an acid-responsive Pickering emulsion encapsulating (PYR@BTIB-PE),...

10.1021/acsami.5c00837 article EN ACS Applied Materials & Interfaces 2025-03-27

The novel targeted Xyloglucan–doxorubicin nanoparticle drug delivery systems (DOX nano-DDSs) exhibited improved cellular uptake, increased accumulation in tumor, higher cytotoxicity against resistant tumor cells and reduced side effects.

10.1039/c6ra01779g article EN RSC Advances 2016-01-01

The emergence of drug-resistant tuberculosis (TB) constitutes a major challenge to TB control programmes. There is an urgent need develop effective anti-TB drugs with novel mechanisms action. Aspartate-semialdehyde dehydrogenase (ASADH) the second enzyme in aspartate metabolic pathway. absence pathway humans and absolute requirement bacteria make ASADH highly attractive drug target. In this study, we used coupled Escherichia coli type III kinase (LysC) establish high-throughput screening...

10.1080/22221751.2021.2006578 article EN cc-by Emerging Microbes & Infections 2021-01-01

ABSTRACT Biodegradable composites from starch and hydrophobic polymer usually show poor compatibility. A novel p ‐phthaloyl chloride‐based prepolymer (PCP) compatibilizer based on chloride polycaprolactone (PCL) diol (2000) was synthesized successfully the chemical structure characterized by Fourier transform infrared spectra 1 H nuclear magnetic resonance (NMR). The PCP compatiblizer mixed with granules to form a coating layer, then coated were melt‐compounded PCL plastic prepare compatible...

10.1002/app.45400 article EN Journal of Applied Polymer Science 2017-06-22

A new type of targeted dual drug delivery system was designed and possesses outstanding advantages over ordinary systems, proving effective against MDR cancer cells.

10.1039/c6ra20437f article EN RSC Advances 2016-01-01

Hepatocellular carcinoma (HCC) is still considered as the third highest cause of cancer death in developing countries.

10.1039/c6ra22633g article EN RSC Advances 2016-01-01

Although epidural analgesia (EA) is recommended for laparotomic (LT) rectal surgery, there no consensus regarding pain management in laparoscopic or robotic (LR) cancer surgery. According to our local guidelines, EA usually chosen LT procedures and intravenous LR procedures.

10.36959/377/375 article EN cc-by Journal of Clinical Anesthesia and Pain Management 2022-12-31
Coming Soon ...